The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists

Bulletin du Cancer

Volumn 97, Issue 3, 2010, Pages

  Monges, Geneviève ^a   Bisot Locard, Ségolène ^b   Blay, Jean Yves ^c   Bouvier, Anne Marie ^d   Urbieta, Marisol ^b   Coindre, Jean Michel ^e   Scoazec, Jean Yves ^f  

^a INSTITUT PAOLI CALMETTES   (France)

^b NOVARTIS PHARMA K K   (Japan)

^c UNIVERSITÉ LYON 1   (France)

^d Chu   (France)

^e INSTITUT BERGONIÉ   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Epidemiological study; Gastrointestinal tumors; Incidence

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RELAPSE; FEMALE; FRANCE; GASTROINTESTINAL STROMAL TUMOR; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; TUMOR LOCALIZATION; TUMOR VOLUME; ADOLESCENT; AGE DISTRIBUTION; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL TRIAL; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; SEX RATIO; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, UNKNOWN PRIMARY; PROSPECTIVE STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77950358011     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1041     Document Type: Article

References (22)

1. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-1220 (Pubitemid 29480891)
2. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002; 38 (Suppl 5): S39-51.
3. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000; 15: 1293-1301
4. Pidhorecky I, Kraybill WG, Gibbs JF, Cheney RT. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7: 705-712
5. Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, et al. Imatinib and solid tumours. Bull Cancer 2008; 95: 99-106.
6. Blay JY, Landi B, Bonvalot S, Monges G, Ray-Coquard I, Duffaud F, et al. Recommendations for the management of GIST patients. Bull Cancer 2005; 92: 907-918
7. Demetri GD, Benjamin RS, Blanke CD, Choi H, Corless C, De Matteo B, Eisenberg B, Fletcher CD. Optimal management of patients with Gastrointestinl Stromal Tumors. JNCCN 2004; Suppl 1.
8. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995; 103: 41-47
9. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465 (Pubitemid 34747864)
10. Miettinen M, Lasota J. Gastrointestinal Stromal Tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478
11. Coindre JM, Emile JF, Monges G, Ranchere D, Scoazec J. Tumeurs stromales gastro-intestinales: définition, caractéristiques histologiques, immunohistochimiques et génétiques, stratégie diagnostique. Ann Pathol 2005 (in press).
12. Corless CL, Heinrich MC. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annu Rev Pathol Mech Dis 2007; 3: 557-586
13. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12. (Pubitemid 32128184)
14. Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer 2005; 103: 821-829 (Pubitemid 40216412)
15. Mucciarini C, Rossi G, Bertolini F et al. Gastrointestinal stromal tumors (GIST): Evaluation of malignancy and prognosis in 113 cases retrieved from a population based Cancer Registry of Northern Italy. ACSO proceeding 2004; 22(4S): 4232.
16. Goettsch WG, Bos SD, Breekveldt-Postma N, Casparie M, Herings RM, Hogendoorn PC. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. Eur J Cancer 2005; 41: 2868-2872 (Pubitemid 41713125)
17. Rubio J, Marcos-Gragera R, Ortiz MR, Miro J, Vilardell L, Girones J, et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur J Cancer 2007; 43: 144-148 (Pubitemid 46054472)
18. Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer 2005; 117: 289-293
19. Tran T, Davila JA, El Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 2005; 100: 162-168
20. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006; 30: 477-489 (Pubitemid 43740149)
21. Steigen SE, Eide TJ. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway. APMIS 2006; 114: 192-200.
22. Theou-Anton N, Tabone S, Brouty-Boye D, Saffroy R, Ronnstrand L, Lemoine A, et al. Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrinemechanism. Br J Cancer 2006; 94: 1180-1185